PANEL DETAILS

Clear Insight and Bright Ideas – Big Data for Medical and Recreational Cannabis Markets

10:35 - 11:25, Vela B (Orion A)
David Berg, Dr. Dean Elterman, John Prentice, Nick Jikomes, Scott Walters

(Panel Discussion) Big data and cloud computing are changing the way businesses and healthcare run around the globe. But one area you might not expect it to be making waves is in the medical and recreational cannabis industry. Cannabis provides a unique challenge for patients, health care providers, researchers and consumer packaged goods because there are so may different types of cannabis (different strains, potencies, ingestion methods and dosing), that it is difficult to scientifically track the individual benefits that are associated with each plant. In the medical world, this is extremely important as dosages and medicines are typically prescribed based on the type of ailment and clinically studied outcomes. From a recreational perspective, its going to be increasingly difficult for vendors and retailers to deal with supply and demand as there is no way easy way to study patient use and consumer preference. Growers and suppliers need know which types of cannabis are most needed and scale up, or down, to emerging consumer and patient needs.

This is where big data comes into focus. Next generation companies such as Strainprint, Ample Organics, Leafly, University Health and Molecular Science Corp are harnessing the power of Big data to drive business and positive consumer outcomes. Learn how this data is used from a Commerical and medical perspective through of these vendors and leading Canadian Cannabinoid Physicians.

SPONSORED BY: STRAINPRINT